GRHL2 expression functions in breast cancer aggressiveness and could serve as prognostic and diagnostic biomarker for breast cancer

X Bai, Y Li, Y Li, F Li, N Che, C Ni… - Clinical Medicine …, 2022 - journals.sagepub.com
Background: Breast cancer (BC) is the most frequent malignancy in women worldwide and
the leading cause of female cancer–associated death in the world. Grainyhead-like 2 …
被引用次数：4 相关文章

GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer.

X Bai, Y Li, Y Li, F Li, N Che, C Ni… - Clinical Medicine …, 2022 - search.ebscohost.com
Background: Breast cancer (BC) is the most frequent malignancy in women worldwide and
the leading cause of female cancer–associated death in the world. Grainyhead-like 2 …

GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer.

X Bai, Y Li, F Li, N Che, C Ni, N Zhao… - Clinical Medicine …, 2022 - europepmc.org
Background Breast cancer (BC) is the most frequent malignancy in women worldwide and
the leading cause of female cancer-associated death in the world. Grainyhead-like 2 …
[HTML] nih.gov

[HTML][HTML] GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer

X Bai, Y Li, Y Li, F Li, N Che, C Ni, N Zhao… - Clinical Medicine …, 2022 - ncbi.nlm.nih.gov
Background: Breast cancer (BC) is the most frequent malignancy in women worldwide and
the leading cause of female cancer–associated death in the world. Grainyhead-like 2 …

GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer

X Bai, Y Li, Y Li, F Li, N Che, C Ni… - Clinical Medicine …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Breast cancer (BC) is the most frequent malignancy in women worldwide and
the leading cause of female cancer-associated death in the world. Grainyhead-like 2 …